Literature DB >> 32908824

Acquired Haemophilia A in Association with Influenza A and Urinary Tract Infection.

Felipe Peña-Muñoz1, Ernesto Parras2, Olga Compan2, Nora Gutiérrez2, Celestino Martin2, José Ramón González-Porras1, Jose María Bastida1.   

Abstract

Acquired haemophilia A (AHA) is a rare autoimmune disorder caused by an autoantibody against any circulating coagulation factor, especially factor VIII (FVIII). The lack of awareness of this condition suggests that diagnosis is a challenge and usually delayed, which leads to suboptimal treatment. Consequently, early diagnosis is mandatory to prevent potentially life-threatening bleeding complications. We present the case of an 85-year-old woman admitted to hospital with symptoms of respiratory infection who 12 hours later developed haematuria which required transfusion. Laboratory assays showed an isolated prolonged aPTT, a moderately reduced FVIII and a high inhibitor titre. Influenza A and Escherichia coli were also identified. Antivirals, antibiotics, immunosuppressive drugs and haemostatic agents were started. Two weeks later, the inhibitor was not detected, and bleeding and symptoms of infection had resolved. Immunosuppressive drugs were stopped on day 45 and there has been no recurrence since then. To date, no FVIII inhibitors have been reported in concomitant infection with influenza A and urinary E. coli. The identification of conditions potentially associated with AHA is essential to achieve complete remission. LEARNING POINTS: The lack of awareness of and experience with acquired haemophilia (AHA) suggests that diagnosis is frequently delayed, resulting in suboptimal treatment.AHA should be suspected in recent-onset abnormal bleeding in patients not receiving anticoagulant treatment, and in the presence of isolated prolonged activated partial thromboplastin time (aPTT).Treatment is based on eradication of the inhibitor, control of the bleeding and identification of underlying conditions. © EFIM 2020.

Entities:  

Keywords:  Acquired haemophilia; bleeding disorders; infectious diseases; influenza

Year:  2020        PMID: 32908824      PMCID: PMC7473680          DOI: 10.12890/2020_001678

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  10 in total

1.  Acquired Hemophilia A in Aged People: A Systematic Review of Case Reports and Case Series.

Authors:  Lidvine Godaert; Seendy Bartholet; Sébastien Colas; Lukshe Kanagaratnam; Jean-Luc Fanon; Moustapha Dramé
Journal:  Semin Hematol       Date:  2018-02-21       Impact factor: 3.851

2.  Acquired haemophilia A associated with HIV infection: a rare disease.

Authors:  Claire Rivoisy; Roselyne D'Oiron; Melanie Cherin; Olivier Ségéral; Jean-Luc Meynard; Thierry Lambert; Cécile Goujard
Journal:  AIDS       Date:  2014-03-27       Impact factor: 4.177

3.  First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.

Authors:  Masahiro Takeyama; Keiji Nogami; Takahiro Kajimoto; Kenichi Ogiwara; Tomoko Matsumoto; Midori Shima
Journal:  Int J Hematol       Date:  2017-06-08       Impact factor: 2.490

Review 4.  Acquired hemophilia A: Updated review of evidence and treatment guidance.

Authors:  Rebecca Kruse-Jarres; Christine L Kempton; Francesco Baudo; Peter W Collins; Paul Knoebl; Cindy A Leissinger; Andreas Tiede; Craig M Kessler
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

5.  Acquired haemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribarivin: role of rituximab.

Authors:  M Á Fernández de Palencia Espinosa; V Arocas Casañ; B Garrido Corro; A de la Rubia Nieto
Journal:  Farm Hosp       Date:  2013 Nov-Dec

6.  Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  P Knoebl; P Marco; F Baudo; P Collins; A Huth-Kühne; L Nemes; F Pellegrini; L Tengborn; H Lévesque
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

7.  Acquired haemophilia A initially diagnosed as angioedema.

Authors:  Asmeret Demissie; Lokesh Shahani; Aziz Khan; Meghna Desai
Journal:  BMJ Case Rep       Date:  2013-08-06

8.  Progressive Intramuscular Haematoma in a 12-Year-Old Boy: A Case of Acquired Haemophilia A.

Authors:  Manori Gamage; Sadeepa Weerasinghe; Mohamed Nasoor; A M P W Karunarathne; Sashi Praba Abeyrathne
Journal:  Case Rep Hematol       Date:  2018-10-24

9.  Innate immune sensing and response to influenza.

Authors:  Bali Pulendran; Mohan S Maddur
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

10.  Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.

Authors:  José María Bastida; María Teresa Cano-Mozo; Felix Lopez-Cadenas; Victor Eduardo Vallejo; Soraya Merchán; Cecilia Santos-Montón; David González-Calle; Javier Carrillo; Ana Africa Martín; Jose Angel Torres-Hernández; Marcos González; Francisco Martín-Herrero; Pedro Pabón; Jose Ramon González-Porras
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  10 in total
  2 in total

1.  Severe acquired haemophilia associated with asymptomatic SARS-CoV-2 infection.

Authors:  Kevin Y Wang; Pratik Shah; Dennis T Roarke; Shams A Shakil
Journal:  BMJ Case Rep       Date:  2021-07-20

2.  Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection.

Authors:  Jeremy W Jacobs; Brian D Adkins; Shannon C Walker; Garrett S Booth; Allison P Wheeler
Journal:  Res Pract Thromb Haemost       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.